23581-42-2Relevant articles and documents
Revisiting the sparteine surrogate: Development of a resolution route to the (-)-sparteine surrogate
Firth, James D.,O'Brien, Peter,Ferris, Leigh
, p. 9357 - 9365 (2015/01/16)
The improved performance of the sparteine surrogate compared to sparteine in a range of applications has highlighted the need to develop an approach to the (-)-sparteine surrogate, previously inaccessible in gram-quantities. A multi-gram scale, chromatography-free synthesis of the racemic sparteine surrogate and its resolution via diastereomeric salt formation with (-)-O,O′-di-p-toluoyl-l-tartaric acid is reported. Resolution on a 10.0 mmol scale gave the diastereomeric salts in 33% yield from which (-)-sparteine surrogate of 937 er was generated. This work solves a key limitation: either enantiomer of the sparteine surrogate can now be readily accessed.
A two-step, formal [4 + 2] approach toward piperidin-4-ones via au catalysis
Cui, Li,Peng, Yu,Zhang, Liming
supporting information; experimental part, p. 8394 - 8395 (2009/10/23)
(Chemical Equation Presented) An efficient, formal [4 + 2] synthesis of synthetically valuable piperidin-4-ones from secondary amines in two steps has been achieved via a key gold catalysis without the purification of tertiary amine intermediates. This reaction is selective toward the less-substituted alkyl group and shows moderate to excellent diastereoselectivities. Its synthetic potential in alkaloid synthesis is demonstratedin a highly diastereoselective synthesis of (±)-cermizine C.
5-HT1F agonists
-
, (2008/06/13)
The present invention relates to a compound of formula (I): or a pharmaceutical acid addition salt thereof; which is useful for activating 5-HT1freceptors and inhibiting protein extravasation in a mammal.